MY109957A - Improved antibodies to plasmodium falciparum - Google Patents

Improved antibodies to plasmodium falciparum

Info

Publication number
MY109957A
MY109957A MYPI93001845A MYPI19931845A MY109957A MY 109957 A MY109957 A MY 109957A MY PI93001845 A MYPI93001845 A MY PI93001845A MY PI19931845 A MYPI19931845 A MY PI19931845A MY 109957 A MY109957 A MY 109957A
Authority
MY
Malaysia
Prior art keywords
plasmodium falciparum
antibodies
improved antibodies
immunoassays
improved
Prior art date
Application number
MYPI93001845A
Other languages
English (en)
Inventor
Melissa Maret S
Dewayne Hahn Gerald
Uithoven Keith
H Feindt Hans
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of MY109957A publication Critical patent/MY109957A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MYPI93001845A 1992-09-11 1993-09-10 Improved antibodies to plasmodium falciparum MY109957A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94528792A 1992-09-11 1992-09-11

Publications (1)

Publication Number Publication Date
MY109957A true MY109957A (en) 1997-10-31

Family

ID=25482919

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI93001845A MY109957A (en) 1992-09-11 1993-09-10 Improved antibodies to plasmodium falciparum

Country Status (10)

Country Link
US (3) US5478741A (cg-RX-API-DMAC10.html)
EP (1) EP0588122B1 (cg-RX-API-DMAC10.html)
JP (1) JP2537589B2 (cg-RX-API-DMAC10.html)
AU (2) AU670108B2 (cg-RX-API-DMAC10.html)
CA (1) CA2104899C (cg-RX-API-DMAC10.html)
DE (1) DE69321914T2 (cg-RX-API-DMAC10.html)
ES (1) ES2124276T3 (cg-RX-API-DMAC10.html)
MY (1) MY109957A (cg-RX-API-DMAC10.html)
SG (1) SG48314A1 (cg-RX-API-DMAC10.html)
TW (1) TW258738B (cg-RX-API-DMAC10.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
GB9505447D0 (en) * 1995-03-17 1995-05-03 Common Services Agency Competitive binding assay
US20030036106A1 (en) * 1996-10-28 2003-02-20 Burke Thomas J. Kinase and phosphatase activity measurement using fluorescence polarization
KR20010012554A (ko) * 1997-05-14 2001-02-15 벤슨 로버트 에이치. 항미생물성 펩티드
US20020102620A1 (en) * 1999-05-07 2002-08-01 S. Melissa Maret Antibodies and peptides for detection of plasmodium vivax
ATE273516T1 (de) * 1999-06-23 2004-08-15 Cornell Res Foundation Inc Entwässerung/rehydratisierung von markierten liposomen auf einer prüfeinrichtung
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
DE60333876D1 (de) 2002-05-31 2010-09-30 Cornell Res Foundation Inc Methoden zum Nachweis Analyten in Proben
AU2003270619A1 (en) 2002-09-12 2004-04-30 Molecular Probes, Inc. Site-specific labeling of affinity tags in fusion proteins
FR2865541B1 (fr) * 2003-05-20 2006-08-11 Commissariat Energie Atomique Procede de detection de fluorure ou de fluorure d'hydrogene et trousse de detection
EP1718967B1 (en) * 2004-02-03 2013-04-24 Diadexus, Inc. METHODS OF DETECTING Lp-PLA2 ACTIVITY
KR101035111B1 (ko) * 2004-06-30 2011-05-19 주식회사 엘지생명과학 말라리아 플라스모듐 팔시파룸의 면역학적 측정방법 및이에 사용되는 측정 수단
JP4599928B2 (ja) * 2004-08-02 2010-12-15 東洋紡績株式会社 ペプチドの固定化方法
JP4508765B2 (ja) * 2004-08-02 2010-07-21 東洋紡績株式会社 ペプチドの固定化方法
US9568471B2 (en) * 2005-01-25 2017-02-14 The Johns Hopkins University Plasmodium diagnostic assay device
DE602006015929D1 (de) * 2005-03-30 2010-09-16 Saladax Biomedical Inc Doxorubicin-immuntest
US20070072242A1 (en) * 2005-09-22 2007-03-29 Randox Laboratories Limited Immunoassay method and kit to leucomalachite green and malachite green
JP2009528988A (ja) * 2006-02-10 2009-08-13 ライフ テクノロジーズ コーポレーション 翻訳後修飾されたタンパク質の標識及び検出方法
CN107573445B (zh) * 2006-05-27 2021-05-25 富鲁达加拿大公司 聚合物骨架元素标签
WO2008008797A2 (en) 2006-07-10 2008-01-17 The Regents Of The University Of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
WO2008039266A2 (en) * 2006-07-28 2008-04-03 Beckman Coulter, Inc. Stabilizing agents and capture ligands for use in assays measuring analyte concentrations
ES2567143T3 (es) * 2006-10-06 2016-04-20 Sirigen Inc. Métodos y materiales fluorescentes para amplificación dirigida de señales de biomarcadores
TWI368905B (en) 2006-11-17 2012-07-21 Princeton Technology Corp Circuits for generating radio frequency zero cross signal of optical disc drive
CA2591496C (en) * 2006-12-18 2014-09-02 Japan Science And Technology Agency Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods
FR2914066B1 (fr) * 2007-03-20 2009-05-22 Polyintell Sarl Kit d'analyse comprenant au moins deux polymeres a empreintes moleculaires et au moins un marqueur, ainsi que le procede d'analyse l'utilisant
US8320230B2 (en) 2007-05-17 2012-11-27 Mediatek Inc. Processing circuits and methods for optical data
US7943370B2 (en) * 2007-08-23 2011-05-17 Canon Kabushiki Kaisha Structure, target substance detection element and target substance detection kit
WO2009097159A1 (en) * 2008-02-02 2009-08-06 Tropical Health Systems Llc A blood purification method and appartus for the treatment of malaria
WO2010051544A2 (en) * 2008-10-31 2010-05-06 Lumiphore, Inc. Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
US9273059B2 (en) 2009-08-24 2016-03-01 Lumiphore, Inc. Macrocyclic HOPO chelators
WO2011079291A1 (en) * 2009-12-24 2011-06-30 Lumiphore, Inc. Radiopharmaceutical complexes
AU2011232632A1 (en) * 2010-03-23 2012-11-01 Board Of Trustees Of Michigan State University Histidine rich protein-2 diagnostic test for cerebral malaria
KR20130107293A (ko) * 2010-09-03 2013-10-01 오레곤 헬스 앤드 사이언스 유니버시티 공유 결합된 펩티드를 갖는 재조합 ｔ 세포 수용체 리간드
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles
KR20160092006A (ko) * 2013-12-03 2016-08-03 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 임신성 당뇨병의 평가를 위한 방법 및 시약
GB201409516D0 (en) * 2014-05-29 2014-07-16 Randox Lab Ltd Immunoassay for compounds of the NBOMe family
WO2016140799A1 (en) * 2015-03-03 2016-09-09 Ark Diagnostics, Inc. Pregabalin immunoassays
WO2016179053A1 (en) 2015-05-01 2016-11-10 BioLegend, Inc. Stable nanomagnetic particle dispersions
US11092595B2 (en) * 2016-02-26 2021-08-17 Agilent Technologies, Inc. Use of bispyridines to improve labeling of nucleophiles
US11181521B2 (en) * 2016-04-05 2021-11-23 Universite De Strasbourg Intra-droplet surface engineering to capture a molecular target
EP4134427A1 (en) 2016-04-30 2023-02-15 Biolegend, Inc. Compositions and methods for performing magnetibuoyant separations
WO2018195008A1 (en) 2017-04-21 2018-10-25 Mellitus, Llc Methods and antibodies for diabetes-related applications
CN120801474A (zh) * 2018-04-13 2025-10-17 富鲁达加拿大公司 用于元素分析的稳定细胞采集
CN111378035B (zh) * 2018-12-29 2021-10-08 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii重组抗体
CN111378034B (zh) * 2018-12-29 2021-10-12 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii抗体
CN114605533B (zh) * 2020-12-08 2023-02-28 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii的抗体、检测恶性疟原虫的试剂和试剂盒
US20220214350A1 (en) * 2021-01-05 2022-07-07 Encodia, Inc. Methods for stable complex formation and related kits

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE388694B (sv) 1975-01-27 1976-10-11 Kabi Ab Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4666866A (en) 1983-04-19 1987-05-19 Krauth Gary H Immunoassay for antigens employing supported binder
US4493795A (en) * 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
US4695554A (en) 1984-02-14 1987-09-22 Becton Dickinson And Company Sac or liposome containing dye (sulforhodamine) for immunoassay
US4743560A (en) 1984-03-26 1988-05-10 Becton Dickinson And Company Solid phase assay
US4632901A (en) 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
GB2169901A (en) 1984-12-11 1986-07-23 Lkb Biochrom Ltd method for a solid phase synthesis of a linear combination of amino acid residues.
EP0217877A4 (en) * 1985-04-11 1988-03-30 Inst Medical W & E Hall VERY REPEATABLE ANTIGENS FROM PLASMODIUM FALCIPARUM.
AU5603786A (en) * 1985-04-11 1986-10-16 Walter And Eliza Hall Institute Of Medical Research, The Highly repetitive antigens - sharp-arp-mesa-plasmodium falciparum
US5130416A (en) * 1986-08-13 1992-07-14 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from plasmodium falciparum
US5030558A (en) 1986-11-07 1991-07-09 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
US4920046A (en) 1987-02-20 1990-04-24 Becton, Dickinson And Company Process, test device, and test kit for a rapid assay having a visible readout
US4855240A (en) 1987-05-13 1989-08-08 Becton Dickinson And Company Solid phase assay employing capillary flow
WO1989001785A1 (en) 1987-09-04 1989-03-09 Georgetown University Monoclonal antibodies to a plasmodium falciparum protein
DE3737238A1 (de) * 1987-11-03 1989-05-18 Behringwerke Ag Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
US4818677A (en) 1987-12-03 1989-04-04 Monoclonal Antibodies, Inc. Membrane assay using focused sample application
US5096837A (en) 1990-02-08 1992-03-17 Pacific Biotech, Inc. Immunochromatographic assay and method of using same
EP0474891A1 (en) * 1990-09-08 1992-03-18 BEHRINGWERKE Aktiengesellschaft Vectors for expression of malarial antigens on the surface of Salmonella vaccine strains
JP2002054521A (ja) 2000-08-11 2002-02-20 Honda Motor Co Ltd エンジンの燃料ポンプ取付構造

Also Published As

Publication number Publication date
AU670108B2 (en) 1996-07-04
AU6449996A (en) 1996-12-12
DE69321914D1 (de) 1998-12-10
AU4487293A (en) 1994-03-17
US5478741A (en) 1995-12-26
US5665552A (en) 1997-09-09
JPH06225789A (ja) 1994-08-16
CA2104899C (en) 2000-10-17
CA2104899A1 (en) 1994-03-12
DE69321914T2 (de) 1999-03-25
AU683000B2 (en) 1997-10-23
ES2124276T3 (es) 1999-02-01
EP0588122B1 (en) 1998-11-04
TW258738B (cg-RX-API-DMAC10.html) 1995-10-01
JP2537589B2 (ja) 1996-09-25
US5604117A (en) 1997-02-18
SG48314A1 (en) 1998-04-17
EP0588122A1 (en) 1994-03-23

Similar Documents

Publication Publication Date Title
MY109957A (en) Improved antibodies to plasmodium falciparum
PT1135498E (pt) Variantes de anticorpos com maior afinidade de ligação em comparação com os anticorpos parentais
NO961151D0 (no) Antistoffer mot CD40
GB9206422D0 (en) Antibody preparation
ES2124533T3 (es) Anticuerpos monoclonales inmunoestimulantes.
DE3574184D1 (en) Support material for the use in immunoassays
EP0636029A4 (en) AGAINST CARCINOMA-ASSOCIATED ANTIQUE ANTIBODIES.
NO991449D0 (no) Antistoff mot human parathormon-relaterte peptider
EP0746398A4 (en) ANTIBODY CLEANING
EP0692536A3 (en) Protein that induces interferon gamma production and monoclonal antibodies against it
EP0870826A4 (en) NEW PROTEINS AND MONOCLONAL ANTIBODIES AGAINST THESE
EP0359063A3 (en) Antibody having high affinity to hapten as antigen and immunogen for obtaining the same
GB2196634B (en) Monoclonal antibodies to hiv and related peptides
GR870872B (en) Layered immunoassay using antibodies bound to transport particles to determine the presence of an antigen
EP0600326A3 (de) Streptolysin O Peptidantigene und Verfahren zur Bestimmung von Streptolysin-Antikörper.
NZ305083A (en) Use of cd40 binding proteins (a cd40 ligand or monoclonal antibody that specifically binds to cd40) for stimulating a immune response
NZ234049A (en) Peptide epitopes of, and antibodies to htlv-1
EP0759943A4 (en) MONOCLONAL ANTIBODIES SPECIFIC TO VASCULAR ENDOTHEL CELL-LIKE ENDOGLYX-1, THE ANTIQUE SELF AND ITS USE
IN172885B (cg-RX-API-DMAC10.html)
WO1999024835A3 (en) An immunoassay for procollagen-iii-c-terminal propeptide
FI943218L (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
FI954827A0 (fi) Monoklonaalisia anti-CD4-vasta-aineita kantavia immuunipartikkeleita ja niiden käyttö
GB9704237D0 (en) Antibodies to fungal antigens
AU2169797A (en) Improved production of antibodies through the use of antigen antibody complexes
IL127249A0 (en) Human monoclonal antibodies to the hepatitis b surface antigen